About Punjab Institute of Cardiology
Punjab Institute of Cardiology, located in Lahore, Pakistan, is a 347-bed tertiary care hospital providing nationwide comprehensive cardiac care services.
Clinical Trials at Punjab Institute of Cardiology
During the past decade, Punjab Institute of Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Punjab Institute of Cardiology"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Higher Education Commission (Pakistan)" with 1 trials as a collaborator, "Pakistan Association of Cognitive Therapists" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Punjab Institute of Cardiology
According to Clinical.Site data, the most researched conditions in "Punjab Institute of Cardiology" are
"Coronary Heart Disease" (1 trials), "Depression" (1 trials), "Myocardial Infarction" (1 trials), "Periodontal Disease" (1 trials) and "Rheumatic Heart Disease" (1 trials). Many other conditions were trialed in "Punjab Institute of Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Punjab Institute of Cardiology
Most popular intervention types in "Punjab Institute of Cardiology" are "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "CaCBT based guided self help using Khushi aur Khatoon Manual" (1 trials), "Delayed treatment" (1 trials), "Periodontal therapy" (1 trials), "Rivaroxaban (20 mg)" (1 trials) and "Vitamin K antagonists (VKA)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Punjab Institute of Cardiology
The vast majority of trials in "Punjab Institute of Cardiology" are
3 trials for "All" genders.
Clinical Trials Status at Punjab Institute of Cardiology
Currently, there are NaN active trials in "Punjab Institute of Cardiology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Punjab Institute of Cardiology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Punjab Institute of Cardiology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".